Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-04-27

Clinical Trial Update: Effects of Nitroglycerin Versus Labetalol on Tissue Perfusion During Deliberate Hypotension [Phase 4]

View source ↗

Summary

Phase 4 trial comparing nitroglycerin versus labetalol for tissue perfusion during deliberate hypotension in sinus endoscopic surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NITROGLYCERIN (Nitroglycerin)
  • labetalol (labetalol hydrochloride)

Snippet

Sponsor: Cairo University | Conditions: Tissue Perfusion, Deliberate Hypotension | Phase 4 | Status: COMPLETED